Care support for hospitalized patients with drug-related infections
Part of Mental health clinical trials.
This study is for people who are in the hospital with a serious infection caused by injection drug use. It aims to provide better care and support while you are in the hospital and after you leave.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You are currently staying in the hospital (not just the ER).
- You have injected opioids or stimulants (like heroin, fentanyl, cocaine, or meth) within the past 3 months.
- You have a serious infection related to your drug use, such as a heart infection, bone infection, bloodstream infection, or deep skin abscess.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a combined care approach to standard treatment for veterans with opioid use disorder. It aims to see if integrated care helps manage both addiction and related infections like HIV or hepatitis. This could mean better overall health and simpler treatment.
This study tests a new intensive outpatient program delivered by video or phone to help people with opioid use disorder (and other substance use disorders) stay on track after leaving the hospital. It may help by offering structured support while you are at home.
This study looks at how people recover from an overdose and get connected to care. It interviews people who have had an overdose to understand their experience and improve access to follow-up services.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This study is for people who come to the emergency department because of an opioid overdose, withdrawal, or related problem. It will collect information about patients' experiences to help improve care and support for opioid use.
This study tests whether a combination of buprenorphine (a medication for opioid addiction) and PrEP (a daily pill to prevent HIV) can help people who are leaving jail or prison stay healthy. It aims to reduce both opioid relapse and HIV risk during the transition back to the community.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.